SM
CSBR icon

Sabby Management’s Champions Oncology CSBR Stock Holding History

Sabby Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-71,700
Closed -$184K – 178
2017
Q2 		$184K Hold
71,700
– – 0.01% 179
2017
Q1 		$227K Sell
71,700
-181,804
-72% -$636K 0.01% 214
2016
Q4 		$641K Sell
253,504
-285,089
-53% -$555K 0.04% 179
2016
Q3 		$905K Sell
538,593
-8,135
-1% -$15.1K 0.03% 190
2016
Q2 		$1.18M Buy
546,728
+251,400
+85% +$786K 0.06% 150
2016
Q1 		$1.07M Buy
295,328
+3,733
+1% +$13.8K 0.05% 152
2015
Q4 		$1.04M Buy
291,595
+122,198
+72% +$525K 0.06% 175
2015
Q3 		$893K Buy
+169,397
New +$1.11M 0.04% 247

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Sabby Management's CSBR Position: Q3 2017 in Review

Sabby Management sold out of Champions Oncology (CSBR) in Q3 2017, closing a stake of 71,700 shares — an estimated $184K sold.

Sabby Management first reported a position in CSBR in Q3 2015 and held it in 8 quarters. The position peaked at $1.18M in Q2 2016. 17 funds tracked by Wall St. Rank hold CSBR as of Q3 2017.

  • Sabby Management reported no remaining Champions Oncology position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 71,700 Champions Oncology shares in Q3 2017, an estimated $184K.
  • Sabby Management first reported a position in Champions Oncology in Q3 2015 and held it in 8 quarters.
  • Sabby Management's Champions Oncology position peaked at $1.18M in Q2 2016.
  • 17 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.